Want to see USNA full AI Analyst Report?
USNA Stock Chart & Stats
$22.53
-$0.56(-1.60%)
At close: 4:00 PM EST
$22.53
-$0.56(-1.60%)
Day’s Range― - ―
52-Week Range$16.60 - $38.32
Previous CloseN/A
Volume19.92K
Average Volume (3M)173.43K
Market Cap
$397.14M
Enterprise Value$190.97M
Total Cash (Recent Filing)$162.75M
Total Debt (Recent Filing)$14.00M
Price to Earnings (P/E)45.5
Beta1.09
Next Earnings
Jul 28, 2026EPS Estimate
0.43Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.47
Shares Outstanding18,463,010
10 Day Avg. Volume170,208
30 Day Avg. Volume173,431
Financial Highlights & Ratios
PEG Ratio-0.46
Price to Book (P/B)0.68
Price to Sales (P/S)0.39
P/FCF Ratio42.35
Enterprise Value/Market Cap0.48
Enterprise Value/Revenue0.21
Enterprise Value/Gross Profit0.27
Enterprise Value/Ebitda2.38
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)1.95
Revenue Forecast (FY)$938.74M
Bulls Say, Bears Say
Bulls Say
High Gross MarginsA ~77% gross margin indicates durable product-level economics for supplements and personal care lines. High gross margins provide pricing flexibility and the ability to absorb SG&A investments while preserving long-term profitability if revenue recovers and scale benefits resume.
Conservative Leverage / Strong Balance SheetVery low debt-to-equity (~0.03) gives USANA financial flexibility to fund omni-channel expansion, inventory builds for retail, and R&D without solvency pressure. Low leverage reduces bankruptcy risk and preserves optionality through economic cycles.
Omni-channel Expansion And Rise Wellness TractionRapid Rise Wellness retail growth and omni-channel adoption (>20% of sales targeted) materially diversifies distribution away from direct-selling. Durable retail partnerships and a successful consumable SKU at Costco scale can drive recurring product demand and reduce reliance on legacy channels.
Bears Say
Weak Cash GenerationLow operating cash flow and minimal free cash flow constrain the firm's ability to self-fund retail inventory, marketing, and margin-improving investments. Persistent weak cash conversion increases reliance on working capital management and limits capacity for shareholder returns or major strategic M&A.
Compressed ProfitabilityA collapse to ~1% net margin signals materially reduced earnings power versus recent years. Sustained margin compression limits reinvestment, heightens sensitivity to revenue variability, and implies the company must execute cost or mix improvements to restore durable returns on capital.
Declining Active Customers In Core MarketsThe direct-selling model depends on an active distributor/customer base; a 12% decline in active customers erodes recurring revenue and makes growth dependent on successful conversion via retail/subscriptions. Structural attrition raises execution risk in restoring long-term organic growth.
USANA Health News
USNA FAQ
What was USANA Health’s price range in the past 12 months?
USANA Health lowest stock price was $16.60 and its highest was $38.32 in the past 12 months.
What is USANA Health’s market cap?
USANA Health’s market cap is $397.14M.
When is USANA Health’s upcoming earnings report date?
USANA Health’s upcoming earnings report date is Jul 28, 2026 which is in 22 days.
How were USANA Health’s earnings last quarter?
USANA Health released its earnings results on May 05, 2026. The company reported $0.61 earnings per share for the quarter, beating the consensus estimate of $0.44 by $0.17.
Is USANA Health overvalued?
According to Wall Street analysts USANA Health’s price is currently Overvalued.
Does USANA Health pay dividends?
USANA Health does not currently pay dividends.
What is USANA Health’s EPS estimate?
USANA Health’s EPS estimate is 0.43.
How many shares outstanding does USANA Health have?
USANA Health has 18,463,010 shares outstanding.
What happened to USANA Health’s price movement after its last earnings report?
USANA Health reported an EPS of $0.61 in its last earnings report, beating expectations of $0.44. Following the earnings report the stock price went up 3.894%.
Which hedge fund is a major shareholder of USANA Health?
Currently, no hedge funds are holding shares in USNA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
USANA Health Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
USNA Sentiment 100%
Sector Average 62%
Sector Average 62%
Hedge Fund Trend
Decreased
By 32.6K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $619.0K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Negative
20 days / 200 days
Momentum
-41.01%
12-Months-Change
Fundamentals
Return on Equity
1.66%
Trailing 12-Months
Asset Growth
-1.02%
Trailing 12-Months
Company Description
USANA Health
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Core nutritional and Hiya Direct-To-Consumer. The company offers USANA nutritional optimizers, including supplements for cardiovascular health, skeletal/structural health, and digestive health; Essentials/CellSentials, such as vitamin and mineral supplements for age group beginning with children 13 months of age; and food products that include meal replacement shakes, snack bars, and other related products for healthy weight management, digestive health, and energy and hydration. It offers Celavive, a skincare regimen for various skin care types and ethnicities; and all other products comprising materials and online tools for associates to build business and marketing of products The company sells its products through retail customers, a subscription model, and direct selling, as well as online. The company was founded in 1992 and is headquartered in Salt Lake City, Utah.
USNA Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed meaningful progress across multiple strategic priorities: sequential recovery in the core nutritional business, strong acceleration and retail traction for Rise Wellness, and international and retail expansion for HYA alongside operational integrations and a sizable R&D pipeline. Near-term pressures include higher customer acquisition costs (HYA), increased SG&A, cash used to support initial retail inventory (Costco), and some uncertainty around retailer cadence and macro risks. On balance, the positive operational momentum, reaffirmed guidance ($925M–$1.0B) and advancing omni-channel mix outweigh the contained near-term costs and risks.View all USNA earnings summariesTechnical Analysis
Ownership Overview
40.82% Insiders
10.58% Mutual Funds
14.15% Other Institutional Investors
22.69% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---